“In the past, if I had lost weight, I got a self-esteem boost, which is almost like dopamine. It makes you crave sex more,” ...

A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 ...

Buying a car is supposed to be an exciting experience, right? You walk into the […] ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

A single dose of the psychedelic drug dimethyltryptamine (DMT), given with psychological support, rapidly reduced depressive symptoms in 34 adults with major depressive disorder, according to a ...

Los Angeles Rams wide receiver Puka Nacua is set for NASCAR’s ‘Speed Seat Thrill Ride’ with Kurt Busch ahead of the Daytona 500, Daytona International Speedway announced.

Eli Lilly and Company (NYSE: LLY) has stockpiled $1.5 billion worth of inventory of its experimental oral weight-loss drug, orforglipron, according to a regulatory filing on Thursday. This significant ...

About 36% of individuals who are on Novo Nordisk's (NVO) Wegovy (semaglutide) pill, which hit the market in January, are new to GLP-1s, a new study found. Healthcare research firm Truveta said that ...

SAN FRANCISCO, Feb 11 (Reuters) - Among early users of Novo Nordisk's (NOVOb.CO), opens new tab new Wegovy weight-loss pill, 36% had no prior experience taking a GLP-1 medication, a new nationwide ...

On Friday, the U.S. Food and Drug Administration said it would take "decisive steps" to restrict GLP-1 ingredients in compounded drugs not approved by the agency. Last week, Hims & Hers announced ...